MD SB201 | 2018 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 17 2018 - 25% progression, died in committee
Action: 2018-03-21 - Hearing 3/21 at 1:00 p.m.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 17 2018 - 25% progression, died in committee
Action: 2018-03-21 - Hearing 3/21 at 1:00 p.m.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requiring a prescription drug or device manufacturer to submit certain average sales prices to the Maryland Department of Health for each calendar quarter within 30 days after the end of the quarter; requiring the Department to make the average sales price submitted by a manufacturer available on the Department's website not later than 10 days after it receives the average sales prices; etc.
Title
Public Health - Prescription Drug Manufacturers - Sales to Wholesale Distributors
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2018-03-21 | Senate | Hearing 3/21 at 1:00 p.m. |
| 2018-02-08 | Senate | Hearing canceled |
| 2018-02-28 | Senate | Hearing 2/28 at 1:00 p.m. |
| 2018-01-29 | Senate | Hearing canceled |
| 2018-01-31 | Senate | Hearing 1/31 at 2:00 p.m. |
| 2018-01-17 | Senate | First Reading Finance |
Subjects
Drugs
Electronic Communication
Health
Health, Department of
Industry and Technology
Pharmacists and Pharmacies
Prices
Public Health
Time
Electronic Communication
Health
Health, Department of
Industry and Technology
Pharmacists and Pharmacies
Prices
Public Health
Time
